Effect of oxidative stress on bone marrow mesenchymal stem cells

Acta Academiae Medicinae Sinicae

Volumn 34, Issue 1, 2012, Pages 90-94

  Lu, Wen Yi ^a   Zhao, Ming Feng ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Bone marrow; Mesenchymal stem cells; Oxidative stress; Signaling pathway

Indexed keywords

DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53; REDOX EFFECTOR FACTOR 1;

APOPTOSIS; BONE MARROW CELL; CELL AGING; CELL DIFFERENTIATION; CELL FUNCTION; CELL HYPOXIA; CELL PROLIFERATION; MESENCHYMAL STEM CELL; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; REVIEW; SIGNAL TRANSDUCTION; CYTOLOGY; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM;

BONE MARROW CELLS; HUMANS; MESENCHYMAL STROMAL CELLS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84859083704     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: 10.3881/j.issn.1000-503X.2012.01.017     Document Type: Review

References (27)

1. Paniushin OV, Domaratskaia EI, Starostin VI. Mesenchymal stem cells: sources, phenotype, and differentiation potential [J]. Izv Akad Nauk Ser Biol, 2006, 33(1):6-25.
2. Zhang W, Su X, Gao Y, et al. Berberine protects mesenchymal stem cells against hypoxia-induced apoptosis in vitro [J]. Biol Pharm Bull, 2009, 32(8):1335-1342.
3. Majumdar MK, Thiede MA, Mosca JD, et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells [J]. J Cell Physiol, 1998, 176(1):57-66. (Pubitemid 28277195)
4. Hosokawa K, Arai F, Yoshihara H. Function of oxidative stress in the regulation of hematopoietic stem cell-niche interaction [J]. Biochem Biophys Res Commun, 2007, 363(3):578-583. (Pubitemid 47513670)
5. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses [J]. Blood, 2005, 105(4):1815-1822. (Pubitemid 40223708)
6. Chen X, Armstrong MA, Li G. Mesenchymal stem cells inimmuno-regulation [J]. Immunol Cell Biol, 2006, 84(5):413-421.
7. Pervaiz S, Taneja R, Ghaffari S. Oxidative stress regulation of stem and progenitor cells [J]. Antioxid Redox Signaling, 2009, 11(11):2777-2789.
8. Wagner W, Horn P, Castoldi M, et al. Replicative senescence of mesenchymal stem cells: a continuous and organized process [J]. PLoS One, 2008, 3(5):e2213.
9. 2-induced senescence-like phenotype in human diploid fibroblasts [J]. Free Radic Biol Med, 2002, 33(10):1334-1346.
10. Downward J. PI3-kinase, Akt and cell survival [J]. Semin Cell Dev Biol, 2004, 15(2):177-182.
11. Plant MO, Wilder CL, Wells A, et al. Multipathway kinase signatures of multipotent stromal cells are predictive for osteogenic differentiation [J]. Stem Cells, 2009, 27(11):2804-2814.
12. Mimeault M, Batra SK. Recent insights into the molecular mechanisms involved in aging and the malignant transformation of adult stem/progenitor cells and their therapeutic implications [J]. Ageing Res Rev, 2009, 8(2):94-112.
13. Yang DG, Liu L, Zheng XY. Cyclin-dependent kinase inhibitor p16 (INK4a) and telomerase may co-modulate endothelial progenitor cells senescence [J]. Ageing Res Rev, 2008, 7(2):137-146.
14. Janzen V, Forkert R, Fleming HE, et al. Stem-cell ageing modified by The cyclin-dependent kinase inhibitor p16INK4a [J]. Nature, 2006, 443(7110):421-426. (Pubitemid 44477274)
15. Matheu A, Maraver A, Klatt P, et al. Delayed ageing through damage protection by the Arf/p53 pathway [J]. Nature, 2007, 448(7151):375-379. (Pubitemid 47080339)
16. Wei H, Li Z, Hu S, et al. Apoptosis of mesenchymal stem cells induced by hydrogen peroxide concerns both endoplasmic reticulum stress and mitochondrial death pathway through regulation of caspases, p38 and JNK[J]. J Cell Biochem, 2010, 111(4):967-978.
17. Dai Z, Li Y, Quarles LD, et al. Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation [J]. Phytomedicine, 2007, 14(12):806-814. (Pubitemid 350017876)
18. Chen CT, Shih YR, Kuo TK, et al. Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells [J]. Stem Cells, 2008, 26(4):960-968.
19. Heo JY, Jing K, Song KS, et al. Downregulation of APE1/Ref-1 is involved in the senescence of mesenchymal stem cells [J]. Stem Cells, 2009, 27(6):1455-1462.
20. Xiao G, Jiang D, Thomas P, et al. MAPK pathways activate and phosphorylate the osteoblast-specific transcripton factor, cbfa1 [J]. J Biol Chem, 2000, 275(6):4453-4459. (Pubitemid 30094689)
21. Forte G, Minieri M, Cossa P, et al. Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation [J]. Stem Cells, 2006, 24(1):23-33.
22. Tamama K, Fan VH, Griffith LG, et al. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells [J]. Stem Cells, 2006, 24(3):686-695. (Pubitemid 44464773)
23. Kratchmarova I, Blagoev B, Haack-Sorensen M, et al. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation [J]. Science, 2005, 308(5727):1472-1477. (Pubitemid 40791302)
24. Wisel S, Khan M, Kuppusamy ML, et al. Pharmacological preconditioning of mesenchymal stem cells with trimetazidine protects hypoxic cells against oxidative stress and enhances recovery of myocardial functionin infarcted heart through Bcl-2 expression [J]. J Pharmacol Exp Ther, 2009, 329(2):543-550.
25. Afzal MR, Haider HKh, Idris NM, et al. Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-κB signaling [J]. Antioxid Redox Signal, 2010, 12(6):693-702.
26. Peterson KM, Aly A, Lerman A, et al. Improved survival of mesenchymal stromal cell after hypoxia preconditioning: role of oxidative stress [J]. Life Sci, 2011, 88(1-2):65-73.